A new role for statins in sepsis
- PMID: 23324213
- PMCID: PMC4056163
- DOI: 10.1186/cc11907
A new role for statins in sepsis
Abstract
Several studies have shown promising results regarding the use of statins as an adjunctive treatment for sepsis. Most of those studies were retrospective or observational in nature. The ASEPSIS trial has reported that the administration of atorvastatin reduced clinical progression of sepsis but did not improve mortality. These findings are promising and further multicenter trials are needed to confirm these outcomes and to establish whether this class of medications will offer utility in this regard.
Comment on
-
Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial).Crit Care. 2012 Dec 11;16(6):R231. doi: 10.1186/cc11895. Crit Care. 2012. PMID: 23232151 Free PMC article. Clinical Trial.
References
-
- Patel JM, Thickett DR, Linhartova L, Melody T, Hawkey P, Barnett A, Jones A, Hong T, Cooke MW, Perkins GD, Gao F. Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial) Crit Care. 2012;17:R231. doi: 10.1186/cc11895. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
